Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer’s Disease
- 23 June 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 76 (3) , 1135-1150
Abstract
Background: Amyloid-β soluble oligomers (Aβo) are believed to be the cause of the pathophysiology underlying Alzheimer’s disease (AD) and are normally detected some two decades before clinical onset of the disease. Retinal pathology associated with AD pathogenesis has previously been reported, including ganglion cell loss, accumulation of Aβ deposits in the retina, and reduction of nerve fiber layer thickness as well as abnormalities of the microvasculature. Objective: This study’s aim is to better understand the relationship between brain and retinal Aβo deposition and in particular to quantify levels of the toxic Aβo as a function of age in the retina of a rodent model of AD. Methods: Retinas and brain tissue from 5×FAD mice were stained with Congo red, Thioflavin-T (Th-T), and Aβ plaque-specific and Aβo-specific antibodies. Results: We show that retinas displayed an age-dependent increase of Th-T-specific amyloid fibrils. Staining with anti-Aβ antibody confirmed the presence of the Aβ plaques in all 5×FAD retinas tested. In contrast, staining with anti-Aβo antibody showed an age-dependent decrease of retinal Aβo. Of note, Aβo was observed mainly in the retinal nuclear layers. Finally, we confirmed the localization of Aβo to neurons, typically accumulating in late endosomes, indicating possible impairment of the endocytic pathway. Conclusion: Our results demonstrate the presence of intraneuronal Aβo in the retina and its accumulation inversely correlated with retinal Aβ plaque deposition, indicating an age-related conversion in this animal model. These results support the development of an early AD diagnostic test targeting Aβo in the eye.Keywords
This publication has 97 references indexed in Scilit:
- Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s diseaseTranslational Psychiatry, 2013
- Soluble Aβ oligomer production and toxicityJournal of Neurochemistry, 2011
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse modelNeuroImage, 2011
- Neuropathology of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer DiseaseArchives of Neurology, 2009
- Structural Classification of Toxic Amyloid OligomersJournal of Biological Chemistry, 2008
- Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe ConsortiumBrain Pathology, 2008
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003